Search
01/08/2025
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial
Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial. NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03738-z. PMID:40450141. IF:50.000(Q1/1D).
01/08/2025
Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy
Scilipoti, P, Moschini, M, Zaurito, P, Longoni, M, De Angelis, M, Afferi, L, Lonati, C, Tremolada, G, Viti, A, Santangelo, A, Pichler, R, Necchi, A, Montorsi, F, Briganti, A, Mari, A, Krajewski, W, Laukthina, E, Pradere, B, Del Giudice, F, Mertens, L, Gallioli, A, Soria, F, Gontero, P, Albisinni, S, Shariat, SF, Carando, R. Prognostic Implications of Patients With Clinically Node Positive Bladder Cancer Undergoing Radical Cystectomy. Clinical Genitourinary Cancer. 2025; 23(4)DOI:10.1016/j.clgc.2025.102377. PMID:40514269. IF:2.700(Q2/3D).
01/08/2025
Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis
Sanguedolce, F, Tedde, A, Basile, G, Di Bello, F, Baboudjian, M, Uleri, A, Mancon, S, Chernysheva, D, Figuls, MR, Gallioli, A, Territo, A, Rouprêt, M, Palou, J, Breda, A. Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis. European Urology Oncology. 2025; 8(4)DOI:10.1016/j.euo.2025.05.021. PMID:40533295. IF:9.300(Q1/1D).
01/08/2025
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (May, 10.1038/s41591-025-03738-z, 2025)
Shore, ND, Powles, TB, Bedke, J, Galsky, MD, Redorta, JP, Ku, JH, Kretkowski, M, Xylinas, E, Alekseev, B, Ye, DW, Guerrero-Ramos, F, Briganti, A, Kulkarni, GS, Brinkmann, J, Calella, AM, Cesari, R, Eccleston, A, Michelon, E, Vermette, J, Wei, CM, Steinberg, GD. Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial (May, 10.1038/s41591-025-03738-z, 2025). NATURE MEDICINE. 2025; 31(8)DOI:10.1038/s41591-025-03894-2. PMID:40691368. IF:50.000(Q1/1D).
23/07/2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma
Afferi, L, Pradere, B, Gallioli, A, Moschini, M, Cannoletta, D, Soria, F, Juvet, T, Potretzke, A, Djaladat, H, Kikuchi, E, Mari, A, Khene, Z, Fujita, K, Raman, JD, Sfakianos, JP, Pfail, JL, Cacciamani, GE, van Doeveren, T, Boormans, JL, Antonelli, A, Jamil, M, Abdollah, F, Ploussard, G, Heidenreich, A, Rieger, C, Daneshmand, S, Boorjian, SA, Sauer, A, Wyler, S, Mattei, A, Rouprêt, M, Rink, M, Shariat, SF, Breda, A, Grossmann, NC. Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinoma. WORLD JOURNAL OF UROLOGY. 2025; 43(1)DOI:10.1007/s00345-025-05815-x. PMID:40699361. IF:2.900(Q2/3D).
16/07/2025
A Systematic Review on the Impact of Pregnancy on Renal Graft Function
Marco, BB, Donmez, MI, Erkul, B, Haberal, HB, Pecoraro, A, Prudhomme, T, Campi, R, Piana, A, Lopez-Abad, A, Boissier, R, Breda, A, Territo, A. A Systematic Review on the Impact of Pregnancy on Renal Graft Function. Journal of Clinical Medicine. 2025; 14(14)DOI:10.3390/jcm14145022. PMID:40725714. IF:2.900(Q1/2D).